IFC Supports B. Braun Melsungen`s local pharmaceuticals manufacturing in Indonesia

News Hour:

IFC, a member of the World Bank Group, will provide a loan equal to 450 billion Indonesian Rupiah (approximately 33 million US Dollars) to B. Braun Melsungen AG operations in Indonesia to help finance construction of a local facility for the manufacturing of high-quality Large Volume Parenterals (LVPs).

LVPs are aqueous solutions in sterile containers for infusion therapy used commonly throughout a hospital stay. These products are now largely imported into Indonesia. Because LVPs are intended for intravenous infusion, they must be sterilized through heat. B. Braun, a German company with over 175 years of experience, will produce at a European manufacturing standard, thus transferring high-quality pharmaceutical manufacturing skills in the Indonesian economy.

“There is great need for high quality health goods and services in Indonesia, and we are excited to contribute to improving the supply of safe products required for practically every hospital patient,” said Stephan Soyka, Managing Director of B. Braun in Indonesia. “We are investing in a state-of-the-art manufacturing facility and in the training of our employees to operate at the highest standards.”

Sérgio Pimenta, IFC Director for Manufacturing, Agribusiness and Services, said, “Investments in high-quality medical goods are one example of how the private sector can support public efforts for expanding universal health coverage, like in Indonesia.”

At just three percent of Gross Domestic Product (GDP), Indonesia’s health expenditure per capita is lower than other middle-income countries, and less than half the seven percent level of developed countries. The government introduced universal health coverage, the Jaminan Kesehatan Nasional (JKN) in 2014 and with plans to roll it out to the entire population in phases by 2019. Demand for hospital care is expected to rise sharply.

IFC is the world’s largest multilateral investor in private healthcare, managing an active portfolio of about $1.3 billion worth of health investments. IFC investments in service providers, pharmaceuticals and medical technology are aimed at promoting greater access to affordable, high-quality healthcare.

Mridha Shihab Mahmud

Mridha Shihab Mahmud is a writer, content editor and photojournalist. He works as a staff reporter at News Hour. He is also involved in humanitarian works through a trust called Safety Assistance For Emergencies (SAFE). Mridha also works as film director. His passion is photography. He is the chief respondent person in Mymensingh Film & Photography Society. Besides professional attachment, he loves graphics designing, painting, digital art and social networking.
No Comments

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Sacred Games exposes Rajshri Deshpande nude [video]
Yageo Corp to acquire Kemet Corp in a $1.8 billion deal
Anurag Kashyap shoots Kubra Saith 7 times nude and made her cry for frontal nudity scene [Video]
A ransomware attack hit computer servers and halted administrative work at Pemex
Paperfly launches delivery services covering 64 districts in Bangladesh
Grameenphone brings in the iPhone 11 series in Bangladesh

Advertisement

News of the Month

Scroll Up
%d bloggers like this: